MeSH tree: C23.550.835.900
For patients with haploidentical hematopoietic cell transplantation (haplo-HCT), the addition of itacitinib to standard graft versus host disease (GvHD) prophylaxis is well tolerated and results in low rates of cytokine release ...
Dec 10, 2024
0
10
As part of the COVID-19 International Research Team, researchers at the Johns Hopkins Kimmel Cancer Center, Children's Hospital of Philadelphia, the University of Pittsburgh and Weill Cornell Medicine discovered a novel cause ...
Dec 2, 2024
0
148
Researchers report results of the first-in-human phase 1 clinical trials of a novel immunotherapy approach for solid tumors expressing glypican-3 (GPC3). A team from Baylor College of Medicine and Texas Children's Cancer ...
Nov 27, 2024
0
38
A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient hospital quality reporting ...
Oct 21, 2024
0
26
Cytokines are regulatory proteins involved in cell proliferation, differentiation, inflammation, and hematopoiesis. An excessive immune response triggered by external viruses can lead to a severe immune reaction known as ...
Oct 10, 2024
0
41
In the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T therapy for multiple myeloma, patients experienced efficacy and safety results similar to those ...
Oct 4, 2024
0
38
In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outpatient basis, patients with relapsed or refractory large B-cell lymphoma (LBCL) responded ...
Sep 30, 2024
0
38
Pediatric sepsis, a major inflammatory response to trauma that can cause organ failure and tissue death, kills about 3.3 million children each year worldwide. The catastrophic overreactions to infection or injury often hit ...
Sep 24, 2024
0
70
Universitätsmedizin Berlin is astounded by the huge improvement seen in a female patient with severe systemic lupus erythematosus (SLE) after being treated with the cancer medication teclistamab. Not long ago, the 23-year-old ...
Sep 5, 2024
0
69
If you're lucky enough to survive a battle with the bloodstream infection sepsis, risks of a recurrence that sends you back to hospital within a month remain high, new data shows.
Sep 2, 2024
0
40
